ABSTRACT

The procedure of developing and maturing immature eggs outside of the body is named in vitro maturation. It is a different way to stimulate hormones. 3D scaffolds are principally essential becautilize they provide oocyte culture a three-dimensional shape that makes the microenvironment more resemble what arises in the body. 3D scaffold-based IVM is a safer method to keep your fertility that helps individuals with cancer and other illnesses that impair the ovaries. Finding out more about how 3D scaffolds impact the growth of oocytes may make ART treatments like in vitro fertilization (IVF) operate better. Reducing risks by lessening the risks of ovarian hyperstimulation syndrome (OHSS), this technique makes ART therapies safer. Utilizing 3D scaffolds is a novel method in reproductive medicine that might transform the way oocytes are grown and kept. This review investigates new concepts in assisted reproductive technology that might transform how we maintain people fertile and make fertility treatments better.

KEYWORDS

In vitro maturation, immature oocytes, 3D scaffolds, assisted reproductive techniques.

REFERENCES 

1) Ahmad MF, Elias MH, Mat Jin N, Abu MA, Syafruddin SE, Zainuddin AA, et al. The spectrum of In Vitro Maturation (IVM) in Clinical Practice: The Current Insight. Front Endocrinol. 2023; 14:1192180.
2) Bahrami M, Cottee PA. Culture conditions for in vitro maturation of oocytes–A review. Reprod Breed. 2022;2(2):31–6.
3) Zhao Y, Liao X, Krysta AE, Bertoldo MJ, Richani D, Gilchrist RB. Capacitation IVM improves cumulus function and oocyte quality in minimally stimulated mice. J Assist Reprod Genet. 2020; 37:77–88.
4) Alper MM, Fautilize r BC. Ovarian stimulation protocols for IVF: is better than less. Reprod Biomed Online. 2017;34(4):345–53.
5) Aboulghar M. Treatment of ovarian hyperstimulation syndrome. Semin Reprod Med. 2010;28(6):532–9.
6) Wright CS, Hovatta O, Margara R, Trew G, Winston RML, Franks S, et al. Effects of follicle-stimulating hormone and serum substitution on the in-vitro growth of human ovarian follicles. Hum Reprod. 1999;14(6):1555–62.
7) Kallen A, Polotsky AJ, Johnson J. Untapped reserves: controlling primordial follicle growth activation. Trends Mol Med. 2018;24(3):319–31.
8) Edwards RG. Meiosis in ovarian oocytes of adult mammals. Nature. 1962;196(4853):446–50.
9) De Vos M, Grynberg M, Ho TM, Yuan Y, Albertini DF, Gilchrist RB. Perspectives on the development and future of oocyte IVM in clinical practice. J Assist Reprod Genet. 2021;38(6):1265–80.
10) Barthelmess EK, Naz RK. Polycystic ovary syndrome: current status and future perspective. Front Biosci (Elite Ed). 2014; 6:104.
11) Xu J, Zelinski MB. Oocyte quality following in vitro follicle development. Biol Reprod. 2022;106(2):291–315.
12) Herraiz S, Buigues A, Díaz-García C, Romeu M, Martínez S, Gómez-Seguí I, et al. Fertility rescue and ovarian follicle growth promotion by bone marrow stem cell infusion. Fertil Steril. 2018;109(5):908–18.
13) Ekman A, Fahlberg L. Predicting the outcome of IVF treatments using forward selection regression and linear discriminant analysis.
14) Chian RC, Li JH, Lim JH, Yoshida H. IVM of human immature oocytes for infertility treatment and fertility preservation. Reprod Med Biol. 2023;22(1):e12524.
15) Zheng X, Guo W, Zeng L, Zheng D, Yang S, Xu Y, et al. In vitro maturation without gonadotropins versus in vitro fertilization with hyperstimulation in women with polycystic ovary syndrome: a non-inferiority randomized controlled trial. Hum Reprod. 2022;37(2):242–53.
16) Baker TG, Neal P. Organ culture of cortical fragments and Graafian follicles from human ovaries. J Anat. 1974;117(Pt 2):361.
17) Devine PJ, Rajapaksa KS, Hoyer PB. In vitro ovarian tissue and organ culture: a review. Front Biosci. 2002;7(4):1979–89.
18) Simon LE, Kumar TR, Duncan FE. In vitro ovarian follicle growth: a comprehensive analysis of key protocol variables. Biol Reprod. 2020;103(3):455–70.
19) Smitz J, Dolmans MM, Donnez J, Fortune JE, Hovatta O, Jewgenow K, et al. Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation. Hum Reprod Update. 2010;16(4):395–414.
20) Hirshfield AN. Development of follicles in the mammalian ovary. Int Rev Cytol. 1991; 124:43–101.
21) Telfer EE, Zelinski MB. Ovarian follicle culture: advances and challenges for human and nonhuman primates. Fertil Steril. 2013;99(6):1523–33.
22) Donnez J, Silber S, Andersen CY, Demeestere I, Piver P, Meirow D, et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med. 2011;43(6):437–50.
23) Silber SJ, Barbey N. Scientific molecular basis for treatment of reproductive failure in the human: an insight into the future. Biochim Biophys Acta. 2012;1822(12):1981–96.
24) Andersen CY, Kristensen SG, Greve T, Schmidt KT. Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients. Future Oncol. 2012;8(5):595–608.
25) Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360(9):902–11.
26) Desai N, Alex A, AbdelHafez F, Calabro A, Goldfarb J, Fleischman A, et al. Three-dimensional in vitro follicle growth: overview of culture models, biomaterials, design parameters and future directions. Reprod Biol Endocrinol. 2010;8(1):1–12.
27) Heise M, Koepsel R, Russell AJ, McGee EA. Calcium alginate microencapsulation of ovarian follicles impacts FSH delivery and follicle morphology. Reprod Biol Endocrinol. 2005; 3:1–8.
28) Hu B, Wang R, Wu D, Long R, Ruan J, Jin L, et al. Prospects for fertility preservation: the ovarian organ function reconstruction techniques for oogenesis, growth and maturation in vitro. Front Physiol. 2023; 14:818.
29) Abir R, Franks S, Mobberley MA, Moore PA, Margara RA, Winston RM. Mechanical isolation and in vitro growth of preantral and small antral human follicles. Fertil Steril. 1997;68(4):682–8.
30) Dolmans MM, Amorim CA. Fertility preservation: construction and utilize of artificial ovaries. Reproduction. 2019;158(5): F15–25.
31) David A, Day JR, Cichon AL, Lefferts A, Cascalho M, Shikanov A. Restoring ovarian endocrine function with encapsulated ovarian allograft in immune competent mice. Ann Biomed Eng. 2017; 45:1685–96.
32) Anderson RA, McLaughlin M, Wallace WHB, Albertini DF, Telfer EE. The immature human ovary shows loss of abnormal follicles and increasing follicle developmental competence through childhood and adolescence. Hum Reprod. 2014;29(1):97–106.
33) Dadashzadeh A, Moghassemi S, Shavandi A, Amorim CA. A review on biomaterials for ovarian tissue engineering. Acta Biomater. 2021; 135:48–63.
34) Santos MA, Kuijk EW, Macklon NS. The impact of ovarian stimulation for IVF on the developing embryo. Reproduction. 2010;139(1):23.
35) Yin H, Kristensen SG, Jiang H, Rasmussen A, Andersen CY. Survival and growth of isolated pre-antral follicles from human ovarian medulla tissue during long-term 3D culture. Hum Reprod. 2016;31(7):1531–9.
36) Picton HM, Harris SE, Muruvi W, Chambers EL. The in vitro growth and maturation of follicles. Reproduction. 2008;136(6):703–15.
37) Hossay C, Donnez J, Dolmans MM. Whole ovary cryopreservation and transplantation: a systematic review of challenges and research developments in animal experiments and humans. J Clin Med. 2020;9(10):3196.
38) Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97(9):3146–54.
39) Donfack NJ, Alves KA, Araújo VR, Cordova A, Figueiredo JR, Smitz J, et al. Expectations and limitations of ovarian tissue transplantation. Zygote. 2017;25(4):391–403.
40) Gu Z, Fu J, Lin H, He Y. Development of 3D bioprinting: From printing methods to biomedical applications. Asian J Pharm Sci. 2020;15(5):529–57.
41) Mastrorocco A, Cacopardo L, Martino NA, Fanelli D, Camillo F, Ciani E, et al. One-step automated bioprinting-based method for cumulus-oocyte complex microencapsulation for 3D in vitro maturation. PLoS One. 2020;15(9): e0238812.
42) Khunmanee S, Park H. Three-dimensional culture for in vitro folliculogenesis in the aspect of methods and materials. Tissue Eng Part B Rev. 2022;28(6):1242–57.
43) Temerario L, Monaco D, Mastrorocco A, Martino NA, Cseh S, Lacalandra GM, et al. New Strategies for Conservation of Gentile di Puglia Sheep Breed, an Autochthonous Capital of Millennial Tradition in Southern Italy. Animals. 2023;13(14):2371.
44) Jing YX, Wang YQ, Li HX, Yue F, Xue SL, Zhang XH. Research progress of in vitro oocyte maturation. Reprod Dev Med. 2021;5(3):183–92.
45) Fernández-Montoro A, Angel-Velez D, Benedetti C, Azari-Dolatabad N, Pascottini OB, Van Soom A, et al. Alternative culture systems for bovine oocyte in vitro maturation: liquid marbles and differentially shaped 96-well plates. Animals. 2023;13(10):1635.
46) Romar R, Cánovas S, Matás C, Gadea J, Coy P. Pig in vitro fertilization: Where are we and where do we go? Theriogenology. 2019; 137:113–21.
47) Suzuki N, Yoshioka N, Takae S, Sugishita Y, Tamura M, Hashimoto S, et al. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod. 2015;30(3):608–15.
48) Smitz J, Dolmans MM, Donnez J, Fortune JE, Hovatta O, Jewgenow K, et al. Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation. Hum Reprod Update. 2010;16(4):395–414.
49) Suzuki N, Yoshioka N, Takae S, Sugishita Y, Tamura M, Hashimoto S, et al. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod. 2015;30(3):608–15.
50) Lonergan P, Fair T. Maturation of oocytes in vitro. Annu Rev Anim Biosci. 2016; 4:255–68.
51) Chian RC, Buckett WM, Tan SL. In-vitro maturation of human oocytes. Reprod Biomed Online. 2004;8(2):148–66.
52) Chian RC, Lim JH, Tan SL. State of the art in in-vitro oocyte maturation. Curr Opin Obstet Gynecol. 2004;16(3):211–9.
53) Fautilize r BC, Devroey P, Yen SS, Gosden R, Crowley WF Jr, Baird DT, et al. Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod. 1999;14(11):2681–6.
54) Zhao C, Sun L, Zhao P. Effects of sperm processing techniques on IVF pregnancy rates: a mini-review. Ther Adv Reprod Health. 2023; 17:26334941231188656.
55) Hatırnaz Ş, Ata B, Hatırnaz ES, Dahan MH, Tannus S, Tan J, et al. Oocyte in vitro maturation: A systematic review. Turk J Obstet Gynecol. 2018;15(2):112.
56) Gong X, Li H, Zhao Y. The improvement and clinical application of human oocyte in vitro maturation (IVM). Reprod Sci. 2022;29(8):2127–35.
57) Eppig JJ, O’Brien M, Wigglesworth K. Mammalian oocyte growth and development in vitro. Mol Reprod Dev. 1996;44(2):260–73.
58) Brevini TA, Pennarossa G, Gandolfi F. A 3D approach to reproduction. Theriogenology. 2020; 150:2–7.
59) Sadeghnia S, Akhondi MM, Hossein G, Mobini S, Hosseini L, Naderi MM, et al. Development of sheep primordial follicles encapsulated in alginate or in ovarian tissue in fresh and vitrified samples. Cryobiology. 2016;72(2):100–5.
60) Camboni A, Van Langendonckt A, Donnez J, Vanacker J, Dolmans MM, Amorim CA. Alginate beads as a tool to handle, cryopreserve and culture isolated human primordial/primary follicles. Cryobiology. 2013;67(1):64–9.
61) Kalirajan C, Dukle A, Nathanael AJ, Oh TH, Manivasagam G. A critical review on polymeric biomaterials for biomedical applications. Polymers. 2021;13(17):3015.
62) Xiang D, Liu Y, Zhou E, Wang Y. Advances in the applications of polymer biomaterials for in vitro follicle culture. Biomed Pharmacother. 2021; 140:111422.
63) Kristensen SG, Andersen CY. Cryopreservation of ovarian tissue: opportunities beyond fertility preservation and a positive view into the future. Front Endocrinol (Lausanne). 2018; 9:347.
64) Peng X, Cheng C, Zhang X, He X, Liu Y. Design and Application Strategies of Natural Polymer Biomaterials in Artificial Ovaries. Ann Biomed Eng. 2023;51(3):461–78.
65) Sun J, Tan H. Alginate-based biomaterials for regenerative medicine applications. Materials (Basel). 2013;6(4):1285–309.
66) Farshidfar N, Iravani S, Varma RS. Alginate-Based Biomaterials in Tissue Engineering and Regenerative Medicine. Mar Drugs. 2023;21(3):189.
67) Xu M, West E, Shea LD, Woodruff TK. Identification of a stage-specific permissive in vitro culture environment for follicle growth and oocyte development. Biol Reprod. 2006;75(6):916–23.
68) Shikanov A, Xu M, Woodruff TK, Shea LD. Interpenetrating fibrin–alginate matrices for in vitro ovarian follicle development. Biomaterials. 2009;30(29):5476–85.
69) Vanacker J, Amorim CA. Alginate: a versatile biomaterial to encapsulate isolated ovarian follicles. Ann Biomed Eng. 2017; 45:1633–49.
70) West ER, Xu M, Woodruff TK, Shea LD. Physical properties of alginate hydrogels and their effects on in vitro follicle development. Biomaterials. 2007;28(30):4439–48.
71) Brito IR, Lima IM, Xu M, Shea LD, Woodruff TK, Figueiredo JR. Three-dimensional systems for in vitro follicular culture: overview of alginate-based matrices. Reprod Fertil Dev. 2014;26(7):915–30.
72) Filatov MA, Khramova YV, Semenova ML. In vitro moutilize ovarian follicle growth and maturation in alginate hydrogel: current state of the art. Acta Naturae. 2015;7(2):48–56.
73) Dorati R, Genta I, Ferrari M, Vigone G, Merico V, Garagna S, et al. Formulation and stability evaluation of 3D alginate beads potentially utilize ful for cumulus–oocyte complexes culture. J Microencapsul. 2016;33(2):137–45.
74) Xu M, West-Farrell ER, Stouffer RL, Shea LD, Woodruff TK, Zelinski MB. Encapsulated three-dimensional culture supports development of nonhuman primate secondary follicles. Biol Reprod. 2009;81(3):587–94.
75) Bertoldo MJ, Walters KA, Ledger WL, Gilchrist RB, Mermillod P, Locatelli Y. In-vitro regulation of primordial follicle activation: challenges for fertility preservation strategies. Reprod Biomed Online. 2018;36(5):491–9.
76) Baba T, Ting AY, Tkachenko O, Xu J, Stouffer RL. Direct actions of androgen, estrogen and anti-Müllerian hormone on primate secondary follicle development in the absence of FSH in vitro. Hum Reprod. 2017;32(12):2456–64.
77) Xu J, Lawson MS, Yeoman RR, Pau KY, Barrett SL, Zelinski MB, et al. Secondary follicle growth and oocyte maturation during encapsulated three-dimensional culture in rhesus monkeys: effects of gonadotrophins, oxygen and fetuin. Hum Reprod. 2011;26(5):1061–72.
78) Picton HM. Therapeutic Potential of In Vitro–Derived Oocytes for the Restoration and Treatment of Female Fertility. Annu Rev Anim Biosci. 2022; 10:281–301.
79) Zarein M, Zarban A, Shoorei H, Gharekhani M, Hassanzadeh-Taheri M. The amelioration of ovarian dysfunction by hesperidin in malathion-treated mice through the overexpression of PCNA and FSHR proteins. Heliyon. 2023;9(12).
80) Kusindarta DL, Wihadmadyatami H. The role of extracellular matrix in tissue regeneration. Tissue Regen. 2018;65.
81) Almeida GHDR, Iglesia RP, Rinaldi JDC, Murai MK, Calomeno CVAQ, da Silva Junior LN, et al. Current Trends on Bioengineering Approaches for Ovarian Microenvironment Reconstruction. Tissue Eng Part B Rev. 2023.
82) Kim EJ, Yang C, Lee J, Youm HW, Lee JR, Suh CS, et al. The new biocompatible material for moutilize ovarian follicle development in three-dimensional in vitro culture systems. Theriogenology. 2020; 144:33–40.
83) Sadr SZ, Fatehi R, Maroufizadeh S, Amorim CA, Ebrahimi B. Utilizing fibrin-alginate and matrigel-alginate for moutilize follicle development in three-dimensional culture systems. Biopreserv Biobank. 2018;16(2):120–7.
84) Khaleghi S, Eivazkhani F, Tavana S, Moini A, Novin MG, Stoyan P, et al. Follicular reconstruction and neo-oogenesis in xenotransplantation of human ovarian isolated cells derived from chemotherapy-induced POF patients. J Biol Eng. 2023;17(1):70.
85) Zhu J, Li Z, Zou Y, Lu G, Ronca A, D’Amora U, et al. Advanced application of collagen-based biomaterials in tissue repair and restoration. J Leather Sci Eng. 2022;4(1):30.
86) Yasin A, Ren Y, Li J, Sheng Y, Cao C, Zhang K. Advances in hyaluronic acid for biomedical applications. Front Bioeng Biotechnol. 2022; 10:910290.
87) Rajabi Z, Yazdekhasti H, Mugahi SMHN, Abbasi M, Kazemnejad S, Shirazi A, et al. Moutilize preantral follicle growth in 3D co-culture system using human menstrual blood mesenchymal stem cell. Reprod Biol. 2018;18(1):122–31.
88) Ai G, Meng M, Guo J, Li C, Zhu J, Liu L, et al. Adipose-derived stem cells promote the repair of chemotherapy-induced premature ovarian failure by inhibiting granulosa cells apoptosis and senescence. Stem Cell Res Ther. 2023;14(1):75.
89) Su J, Ding L, Cheng J, Yang J, Li XA, Yan G, et al. Transplantation of adipose-derived stem cells combined with collagen scaffolds restores ovarian function in a rat model of premature ovarian insufficiency. Hum Reprod. 2016;31(5):1075–86.
90) Healy MW, Dolitsky SN, Villancio-Wolter M, Raghavan M, Tillman AR, Morgan NY, et al. Creating an artificial 3-dimensional ovarian follicle culture system using a microfluidic system. Micromachines. 2021;12(3):261.
91) Khunmanee S, Park H. Three-dimensional culture for in vitro folliculogenesis in the aspect of methods and materials. Tissue Eng Part B Rev. 2022;28(6):1242–57.
92) Bian S, He M, Sui J, Cai H, Sun Y, Liang J, et al. The self-crosslinking smart hyaluronic acid hydrogels as injectable three-dimensional scaffolds for cells culture. Colloids Surf B Biointerfaces. 2016; 140:392–402.
93) Desai N, Abdelhafez F, Calabro A, Falcone T. Three-dimensional culture of fresh and vitrified moutilize pre-antral follicles in a hyaluronan-based hydrogel: a preliminary investigation of a novel biomaterial for in vitro follicle maturation. Reprod Biol Endocrinol. 2012;10(1):1–12.
94) Sanz-Horta R, Matesanz A, Gallardo A, Reinecke H, Jorcano JL, Acedo P, et al. Technological advances in fibrin for tissue engineering. J Tissue Eng. 2023; 14:20417314231190288.
95) Zelinski M. Encapsulated three-dimensional (3-D) culture of ovarian follicles for female fertility preservation: A decade of experience and future directions. [Details missing—please provide journal, year, etc.]
96) Luyckx V, Dolmans MM, Vanacker J, Legat C, Moya CF, Donnez J, et al. A new step toward the artificial ovary: survival and proliferation of isolated murine follicles after autologous transplantation in a fibrin scaffold. Fertil Steril. 2014;101(4):1149–56.
97) Wang W, Pei C, Isachenko E, Zhou Y, Wang M, Rahimi G, et al. Automatic evaluation for bioengineering of human artificial ovary: A model for fertility preservation for prepubertal female patients with a malignant tumor. Int J Mol Sci. 2022;23(20):12419.
98) Paulini F, Vilela JM, Chiti MC, Donnez J, Jadoul P, Dolmans MM, et al. Survival and growth of human preantral follicles after cryopreservation of ovarian tissue, follicle isolation and short-term xenografting. Reprod Biomed Online. 2016;33(3):425–32.
99) Chiti MC, Dolmans MM, Mortiaux L, Zhuge F, Ouni E, Shahri PAK, et al. A novel fibrin-based artificial ovary prototype resembling human ovarian tissue in terms of architecture and rigidity. J Assist Reprod Genet. 2018; 35:41–8.
100) Dolmans MM. From isolated follicles to the artificial ovary: Why and how? Curr Opin Endocr Metab Res. 2021; 18:62–8.
101) Das M, Son WY. In vitro maturation (IVM) of human immature oocytes: is it still relevant? Reprod Biol Endocrinol. 2023;21(1):110.
102) Labrune E, Salle B, Lornage J. An update on in vitro folliculogenesis: a new technique for post-cancer fertility. Biomedicines. 2022;10(9):2217.
103) Shahsavari MH, Alves KA, Alves BG, de Lima LF, Vizcarra DAM, Berrocal DJD, et al. Impacts of different synthetic polymers on vitrification of ovarian tissue. Cryobiology. 2020; 94:66–72.
104) Canosa S, Revelli A, Gennarelli G, Cormio G, Loizzi V, Arezzo F, et al. Innovative Strategies for Fertility Preservation in Female Cancer Survivors: New Hope from Artificial Ovary Construction and Stem Cell-Derived Neo-Folliculogenesis. Healthcare. 2023 Oct;11(20):2748.
105) Dadashzadeh A, Moghassemi S, Shavandi A, Amorim CA. A review on biomaterials for ovarian tissue engineering. Acta Biomater. 2021; 135:48–63.
106) Casarin M, Todesco M, Fontanella CG, Morlacco A, Dal Moro F, Bagno A. Hybrid materials for Tissue Repair and Replacement: Another Frontier in Biomaterial Exploitation Focusing on Cardiovascular and Urological Fields. [Details missing—please provide journal, year, etc.]
107) Kim J, Perez AS, Claflin J, David A, Zhou H, Shikanov A. Synthetic hydrogel supports the function and regeneration of artificial ovarian tissue in mice. NPJ Regen Med. 2016;1(1):1–8.
108) Weaver JD, Headen DM, Coronel MM, Hunckler MD, Shirwan H, García AJ. Synthetic poly (ethylene glycol)-based microfluidic islet encapsulation reduces graft volume for delivery to highly vascularized and retrievable transplant site. Am J Transplant. 2019;19(5):1315–27.
109) De Toni T, Stock AA, Devaux F, Gonzalez GC, Nunez K, Rubanich JC, et al. Parallel evaluation of polyethylene glycol conformal coating and alginate microencapsulation as immunoisolation strategies for pancreatic islet transplantation. Front Bioeng Biotechnol. 2022; 10:886483.
110) Buckenmeyer MJ, Sukhwani M, Iftikhar A, Nolfi AL, Xian Z, Dadi S, et al. A bioengineered in situ ovary (ISO) supports follicle engraftment and live-births post-chemotherapy. J Tissue Eng. 2023; 14:20417314231197282.
111) Nam S, Stowers R, Lou J, Xia Y, Chaudhuri O. Varying PEG density to control stress relaxation in alginate-PEG hydrogels for 3D cell culture studies. Biomaterials. 2019; 200:15–24.